Christopher Ryan

Associate Professor

Emailryanc@ohsu.edu

4038 Citations
34 h-Index

If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

21 Similar Profiles

docetaxel Medicine & Life Sciences

Prostatic Neoplasms Medicine & Life Sciences

Androgens Medicine & Life Sciences

Renal Cell Carcinoma Medicine & Life Sciences

Therapeutics Medicine & Life Sciences

Sarcoma Medicine & Life Sciences

Prostate-Specific Antigen Medicine & Life Sciences

Drug Therapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2011 2016

1 Finished

Shutter-Speed Model DCE-MRI for Assessment of Response to Cancer Therapy

Huang, W. & Ryan, C.

National Institutes of Health

9/1/11 → 8/31/16

Project: Research project › Research Project--Cooperative Agreements

Biomarkers

Neoplasms

Therapeutics

Blood Vessels

Water

Research Output 1998 2018

4038 Citations
34 h-Index
83 Article
1 Chapter
1 Review article

Adjuvant Vascular Endothelial Growth Factor–targeted Therapy in Renal Cell Carcinoma: A Systematic Review and Pooled Analysis

Sun, M., Marconi, L., Eisen, T., Escudier, B., Giles, R. H., Haas, N. B., Harshman, L. C., Quinn, D. I., Larkin, J., Pal, S. K., Powles, T., Ryan, C. W., Sternberg, C. N., Uzzo, R., Choueiri, T. K. & Bex, A. Jan 1 2018 (Accepted/In press) In : European Urology.

Research output: Contribution to journal › Article

Renal Cell Carcinoma

Vascular Endothelial Growth Factor A

Vascular Endothelial Growth Factor Receptor

Disease-Free Survival

Placebos

Epirubicin and Ifosfamide with Preoperative Radiation for High-Risk Soft Tissue Sarcomas

Lu, E., Perlewitz, K. S., Hayden, J. B., Hung, A. Y., Doung, Y. C., Davis, L. E., Mansoor, A., Vetto, J. T., Billingsley, K. G., Kaempf, A., Park, B. & Ryan, C. W. Apr 1 2018 In : Annals of Surgical Oncology. 25, 4, p. 920-927 8 p.

Research output: Contribution to journal › Article

Epirubicin

Ifosfamide

Sarcoma

Radiation

Extremities

14 Citations

Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033

Heinrich, M. C., Rankin, C., Blanke, C. D., Demetri, G. D., Borden, E. C., Ryan, C. W., von Mehren, M., Blackstein, M. E., Priebat, D. A., Tap, W. D., Maki, R. G., Corless, C. L., Fletcher, J. A., Owzar, K., Crowley, J. J., Benjamin, R. S. & Baker, L. H. Jul 1 2017 In : JAMA oncology. 3, 7, p. 944-952 9 p.

Research output: Contribution to journal › Article

Gastrointestinal Stromal Tumors

Survival

Mutation

Survivors

Succinate Dehydrogenase

1 Citations

Dosing strategies and optimization of targeted therapy in advanced renal cell carcinoma

Ryan, C. W. Jan 1 2017 In : Journal of Oncology Pharmacy Practice. 23, 1, p. 43-55 13 p.

Research output: Contribution to journal › Review article

Renal Cell Carcinoma

Therapeutics

Sirolimus

Standard of Care

Interferons

14 Citations

Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): An international, multicentre, open-label, randomised phase 3 trial

Tap, W. D. , Papai, Z. , Van Tine, B. A. , Attia, S. , Ganjoo, K. N. , Jones, R. L. , Schuetze, S. , Reed, D. , Chawla, S. P. , Riedel, R. F. , Krarup-Hansen, A. , Toulmonde, M. , Ray-Coquard, I. , Hohenberger, P. , Grignani, G. , Cranmer, L. D. , Okuno, S. , Agulnik, M. , Read, W. , Ryan, C. W. & 8 others Alcindor, T., del Muro, X. F. G., Budd, G. T., Tawbi, H., Pearce, T., Kroll, S., Reinke, D. K. & Schöffski, P. 2017 (Accepted/In press) In : The Lancet Oncology.

Research output: Contribution to journal › Article

Sarcoma

Doxorubicin

Survival

TH 302

Therapeutics